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Abstract
OBJECTIVE: To explore the short and long-term ef-
ficacy of combining Fuzhengliqi mixture (FLM) with
acupuncture in treating functional constipation
(FC).
METHODS: The 560 patients with confirmed diag-
nosis of FC were randomly assigned to four groups:
FLM group, acupuncture group, combined therapy
group, and control group. There were 140 cases in
each group. The FLM group was administered FLM
60 mL twice a day, while the acupuncture group
was treated with acupuncture at acupoints Tianshu
(ST 25), Shangjuxu (ST 37), Zusanli (ST 36),
Dachangshu (BL 25), and Zhigou (TE 6) twice a day,
the combined therapy group with FLM and acu-
puncture, and the control group was administered
mosapride (5 mg thrice a day) and Macrogol 4000
(10 g twice a day). The treatment lasted 6 weeks.
The defecation interval, stool property, constipa-
tion symptoms, and accompanying symptoms
were recorded, graded, and scored. The gastrointes-
tinal transit time (GITT) and motilin (MTL) level in
serum and life quality score were detected at three
time points (pre-treatment, at the end of treat-
ment, and 60 weeks post-treatment). Moreover, the
adverse reactions were also observed.
RESULTS: In the FLM group 2 cases were eliminat-
ed for not taking medication strictly according to
the research plan and 1 case was lost to follow-up,
while 2 cases in the acupuncture group and 2 cases
in the combined therapy group were lost to fol-
low-up. Compared with those detected pre-treat-
ment, the defecation interval, stool property, consti-
pation symptom grade, accompanying symptom
grade, and GITT were all decreased markedly at the
end of treatment in every group, while the MTL lev-
els in serum and life quality score were increased
markedly (P<0.01), the above-mentioned detecting
indices were better in the combined therapy group
than those in other groups (P<0.05). Compared
with the end of treatment, above-mentioned de-
tecting indices all recurred significantly in the FLM
group and control group 60 weeks post-treatment
(P>0.05), but these indices recurred insignificantly
in the acupuncture and combined therapy groups
(P>0.05). The short and long-term total effective
rates in the combined therapy group were signifi-
cantly different from those in other groups (P<0.05
or P<0.01). No serious adverse reactions were
found in four groups.
CONCLUSION: Both FLM and acupuncture can sig-
nificantly shorten the defecation interval and GITT,
increase MTL levels in serum, decrease the scores
of stool property, constipation symptoms, and ac-
companying symptoms in patients with FC to in-
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crease their life quality. The combined therapy is
much better in long-term efficacy and the safety is
also good, worth spreading in clinical practice.
© 2013 JTCM. All rights reserved.
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combinations; Acupuncture; Defecation; Constipa-
tion; Gastrointestinal transit
INTRODUCTION
Functional constipation (FC) is a functional bowel dis-
ease, characterized by continuously difficult, infre-
quent or incomplete defecation sense, and it does not
conform to the diagnostic criteria of irritable bowel
syndrome. FC is a common problem in clinical prac-
tice and 2%-27% of individuals in western countries
suffer from constipation.1 In the Asian population, a
prevalence of 14% has been reported for FC, which se-
verely influences quality of life and may lead to colon
cancer, anal fissure, hemorrhoids, and so on, and also
the abuse of related drugs may induce many adverse ef-
fects.2,3 In recent years, the combined administration of
osmotic laxatives and gastrointestinal prokinetic agent
in treatment of FC have achieved a good result in ef-
fect,4,5 but with a long therapeutic course, a heavy eco-
nomic burden for the patient, and a high recurrence
rate after ceasing the drugs. Clinically, both acupunc-
ture and traditional Chinese medicines have satisfacto-
ry effects on FC.
In the very study, 560 cases of FC were treated with Fu-
zhengliqi mixture (FLM) and acupuncture and the
changes of defecate frequencies, stool property, consti-
pation symptom grade, accompanying symptom grade,
gastrointestinal transit time (GITT), including total
gastrointestinal transit time (TGITT), mouth-intestine
transit time (M-ITT), colonic transit time (CTT),
right colonic transit time (RCTT), left colonic transit
time (LCTT), and rectosigmoid colonic transit time
(RSTT), motilin (MTL) level in serum, and adverse re-
actions were observed pre-treatment (T1), at the end of
treatment (T2), and 60 weeks after treatment (T3) in
the four groups, with mosapride and Macrogol 4000
used as controls, so as to explore the clinical efficacy,
safety, and the therapeutic mechanism of combining
FLM with acupuncture on FC. A report follows.
METHODS
Diagnostic criteria
In accordance with the diagnostic criteria for function-
al gastrointestinal disease in Rome-Ⅲ,functional consti-
pation was defined as follows:6
1) At least in recent 3-6 months before diagnosis, the
patient had the following 2 or more than 2 symptoms:
at least 25% defecation was difficult, at least 25% stool
was hard, at least 25% defecation was with incomplete
evacuation sense, at least 25% defecation was with anal
and rectal obstruction sense, at least 25% defecation
needed help with hand, less than 3 times of defecation
each week. 2) If purgative was not administrated, few
soft stool would be seen. 3) The diagnostic criteria did
not conform to the diagnostic criteria for irritable bow-
el syndrome.
Inclusive criteria
1) The patient aged 17-69 years, male and/or female.
2) The patient conformed to above diagnostic criteria
of functional constipation. 3) Organic lesion was ex-
cluded by endoscope or barium enema examination
within 3 months. 4) Patients did not receive drugs that
could influence the outcome of trial (for example, Laxa-
tive, gastro-intestinal dynamic agents, anticholinergic
drugs, etc.) in one week before entering the trial. 5)
The patients voluntarily signed the informed consent
form.
Exclusive criteria
1) Patients had functional constipation alike symptoms
caused by various organic lesions, such as tumor,
Crohn's disease, colon polyp, tuberculosis of colon,
etc. 2) Women in pregnant or lactation stage. 3) Pa-
tients who were hypersensitive to the testing drug. 4)
Patients complicated with serious primary diseases of
heart, blood vessels, liver, kidney or hematopoietic sys-
tem, and mental diseases.
Elimination criteria
1) The patient was found not conform to inclusive cri-
teria during the research process. 2) The patient did
not take medicine according to the research plan.
Loss criteria
1) The patient was unwilling to continue participating
in the trial for various reasons. 2) The patient was unfit
for the trial for severe complications.
Subjects
All of the 560 cases were out- or in-patients of the Gas-
troenterology Department from September 2009 to
August 2011, and they were definitely diagnosed and
other local or general lesion was excluded after various
relative examinations. According to their visiting order,
the patients were randomized into four groups: FLM
group, acupuncture group, combination group, and
control group, with 140 cases in each. In the process of
treatment and follow-up, 2 cases in the FLM group
were eliminated for not taking medicine strictly accord-
ing to the research plan and 1 case was lost to fol-
low-up, while 2 cases in the acupuncture group and 2
cases in the combination group were lost to follow-up.
So there were finally 553 cases who were analyzed sta-
tistically as follows, 1) in the FLM group, 70 cases
were male and 67 female; aged 17-62 years, averaged
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(43±11) years; duration of illness was 6 months- 11.0
years with a mean of (5±3) years; in degrees of lesion,
37 cases were mild (total symptom grade≤13), 51 were
moderate (14 ≤total symptom grade ≤23), and 49 were
severe (total symptom grade >23); (2) in the acupunc-
ture group, 71 cases were male and 67 female; aged
18-61 years, averaged (43±14) years; duration of illness
was 7 months-12.0 years with a mean of (5±3) years;
in degrees of lesion, 38 cases were mild, 48 were mod-
erate, and 52 were severe; (3) in the combination
group, 72 cases were male and 66 female; aged 17-62
years, averaged (41±12) years; duration of illness was 5
months-11.0 years with a mean of (5±4) years; in de-
grees of lesion, 41 cases were mild, 47 were moderate,
and 50 were severe; and (4) in the control group, 72
cases were male and 68 female; aged 18-61 years, aver-
aged (42 ± 10) years; duration of illness was 5
months-11.0 years with a mean of (5±4) years; in de-
grees of lesion, 40 cases were mild, 48 were moderate,
and 52 were severe. There were no statistically signifi-
cant differences among the four groups in sex, age and
duration of illness, and so on (all P>0.05), with the
comparability.
Treatment
The FLM group was administered FLM (200 mL/ bot-
tle, produced by the First Affiliated Hospital of Xinx-
iang Medical University, instrument of ratification No:
Z04070031) 60 mL twice daily for 6 weeks.
The acupuncture group was treated with acupuncture
at Tianshu (ST 25), Shangjuxu (ST 37), Zusanli (ST
36), Dachangshu (BL 25), and Zhigou (TE 6) twice a
day with an operation as fellows: the patient was in a
supine position and the selected points were routinely
disinfected, Hwato brand needles 0.38 mm in diame-
ter and 50-80 mm in length were used, the operator
held the needle with right hand and inserted it into the
subcutaneous level about 35-65 mm deep with a 90o
angle between the needle body and the patient skin,
the needles were manipulated for getting arrival of Qi,
then connected with a G6805 electroacupuncture in-
strument, at frequency 2 Hz/200 Hz, and the current
intensity would be adjusted to the patient's endurance
as making abdominal muscle of the patient slightly vi-
brated, the needles were retained for 15 min each time,
the acupuncture treatment was applied twice daily.
One therapeutic course consisted of one week with an
interval of 2 days between two courses. The treatment
lasted for 6 weeks in all.
The combination group was treated with above-men-
tioned FLM and acupuncture.
The control group was administered mosapride (5 mg/
piece, produced by Lunan BeitePharmaceutical Co.
Ltd., instrument of ratification No. H19990317) 5 mg
three times daily and Macrogol 4000 (produced by Bo-
fu Yipusheng Industrial Co. France, Import drugs regis-
tration No. H 20030123) 10g twice daily for 6 weeks.
Observation indices
Defecation interval: the defecation interval and its
score were calculated according to the patient's diary
card. Points 0-3 were marked according to defecation
interval: 0 score denoted normal defecation interval
(1-2 days); 1 score denoted slightly extended defeca-
tion interval (3 days); 2 scores denoted moderately ex-
tended defecation interval (4-5 days); 3 scores denoted
obviously extended interval (6-7 days); 4 scores denot-
ed extremely extended interval (>7 days).
Stool property: according to Bristol stool property typ-
ing,7 type 1: separative hard mass; type 2: mass; type 3:
dry and cracked sausage-like shape; type 4: soft sau-
sage-like shape; type 5: soft mass. Type1, 2, and 3 were
abnormal and type 4 and 5 were normal. Criteria for
evaluating scores of stool property: type 3 was 1, type 2
was 2, and type 1 was 3, and the stool property scores
each week were calculated.
Defecation difficult degrees:7 points 0-3 were assessed
according to severe degrees: 0 score denoted no defec-
tion difficulty; 1 score denoted hard defecation; 2
scores denoted very hard defecation with stool of mass
or hard knot; 3 scores denoted defecation with an un-
finished sense or with anal blocking sense or anal-rectal
infarction; 4 scores denoted defecation needing help
with manipulation, such as massaging around the anal
even to scratch out with hand. The mean score of each
patient was calculated.
Accompanying symptoms: the scores of the main ac-
companying symptoms, including abdominal pain, ab-
dominal distension, and anorexia, were assessed sepa-
rately according to the severity and frequency. Points
0-3 were assessed according to severe degrees: 0 score
denoted no symptom; 1 score denoted mild symptom
only be reminded when awaking; 2 scores denoted ob-
vious subjective symptoms without influencing pa-
tient's work and life; 3 scores denoted severe symptoms
that influenced work and life of the patient. The sum
of scores on the severity of three symptoms constituted
the total score of symptom severity. Points 0-3 were
marked according to symptom frequency: 0 score de-
noted no attack; 1 score denoted low frequency (≤3
times/week) of attack; 2 scores denoted moderate fre-
quency (>3 but <7 times/week); 3 scores denoted high
frequency (>7 times/week). The product of total score
of symptoms' severity and frequency was calculated
and regarded as the total symptom score. It was mea-
sured at the designed three time points (T1, T2, and
T3) for comparing.
GITT: in reference to the literature,8 GITT, including
TGITT, M-ITT, CTT, RCTT, LCTT and RSTT was
detected by using the strip-form opaque X-ray marker
(20 pieces were filled in a capsule) produced by Beijing
Institute of Space Medical Engineering. After getting
up in the morning of the test day, the stool was evacu-
ated, and at 8 o'clock in the morning, one capsule
filled with the opaque X-ray marker was orally adminis-
tered, and the abnormal plain films were taken at 24,
48, and 72 h. With the fifth lumbar vertebral spinous
process as the center, upwards drawing the median ab-
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dominal line, and towards the right-inferior drawing a
tangent line till right entrance edge of pelvis, and to-
wards the left drawing a tangent line linking to the pos-
terior superior iliac spine. The right side of the median
abdominal line was the R area, the left side was the LC
area, and that below the two tangent lines was the RS
area. The residual number of the marker in the 3 differ-
ent regions was recorded in different periods.
Formula: 50%TT%(h)=TA+(TB-TA)(10–NA)/(NA-NB).
Among them, TA and TB respectively were the hours
from the oral administration of marker to taking the
film on the abdominal plain film, and NA and NB re-
spectively were the marker numbers passing a certain
point at TA and TB.
PlasmaMTL: 4mL of blood was obtained from the cubi-
tal vein of each subject in fasting condition and 30 min
after meal, then immediately centrifuged in a 5 mL
centrifugal tube and immediately frozen at -20℃ . The
level of plasma motilin was determined by using MTL
radioimmunoassay kit and GC - 1200γ type radioim-
munoassay counter in the central laboratory of the
First Affiliated Hospital of Xinxiang Medical College.
Assessment of life quality: short Form 36 Health Sur-
vey Questionnaires (SF 36)9 included 36 clauses, 8 do-
mains of physical function (PF), role physical (RP),
role emotional (RE), social function (SF), mental
health (MH), vitality (VT), bodily pain (BP), and gen-
eral health (GH). Scores ranged 0-100, a higher score
represented a better quality of life.
Assessment of curative effect
1) Short-term efficacy index = (total symptom score
pre-treatment - total symptom score at the end of treat-
ment) ÷ total symptom score pre-treatment × 100%. 2)
Long-term efficacy index = (total symptom score
pre-treatment - total symptom score 60 weeks after treat-
ment) ÷ total symptom score pre-treatment × 100%. 3)
The efficacy index >75% was regarded as marked effec-
tive, while 51%-75% as effective, 26%-50% as im-
proved, ≤25% as ineffective.
Adverse reaction examination: physical examination,
routine examination of blood, urine, stool, functions
of liver and kidney, electrolytes, colon microscopy, elec-
trocardiogram were carried out in the patients of the
four groups before treatment, at the end of treatment,
and 60 weeks after treatment.
Statistical analysis
The measurement data were expressed by xˉ ±s, compar-
ison between groups was performed with t-test, the da-
ta were analyzed with SPSS 13.0, and P<0.05 was sig-
nificant level.
RESULTS
Comparison of defecation interval, stool property, con-
stipation symptom grade, accompanying symptom
grade, GITT, MTL level, and life quality at T1, T2, and
T3 in the four groups.
Compared with the same group at T1, the MTL levels
and scores of 8 dimensions of life quality were all in-
creased significantly at T2 in all groups, while the defe-
cation interval, stool property, constipation symptom
grade, accompanying symptom grade, and GITT were
all decreased significantly (P<0.01); The above-men-
tioned detecting indices were better in the combined
therapy group than those in other groups (P<0.05).
Compared with the same group at T2, the above-men-
tioned detecting indices recurred insignificantly in the
combined therapy group and acupuncture group at T3
(P>0.05), but these indices all recurred significantly in
the FLM group and control group (P<0.05).
The above-mentioned detecting indices in the acupunc-
ture group at T3 were better than those in the FLM
group and control group, and the above-mentioned de-
tecting indices were better in the combined therapy
group than those in other groups (P<0.05, P<0.01, Ta-
ble 1-4).
Effective rates
The short-term efficacy was better in the combined
therapy group than that in other groups (all P<0.05);
compared with the short-term efficacy in the same
group, the long-term efficacy decreased insignificantly
in the combined therapy and acupuncture groups (P>
0.05), but the long-term efficacy all decreased signifi-
cantly in the FLM and control groups (P<0.05).
The long-term efficacy in the acupuncture group was
better than that in the FLM and control groups, and
the long-term efficacy was better in the combined ther-
apy group than that in other groups (P<0.05, P<0.01,
Table 5).
Adverse reactions
In the control group, 2 cases had mild diarrhea at the
initial stage of the treatment with no special treatment,
and 5 days later it alleviated spontaneously. In other
groups, there was no adverse reaction. And in the pa-
tients of the four groups, there were no obvious chang-
es in physical examination, blood, urine and stool rou-
tine examination, functions of liver and kidney, electro-
lytes, colon microscopy, and electrocardiogram.
DISCUSSION
FC has a complex etiology and brings many troubles to
patients. With the development of society, increase of
life pressure and the change of diet structure, its inci-
dence is increasing and severely influences life quality
of patients. Purgative abuse is very popular in the pa-
tients with constipation. At present, the drugs used for
treatment of chronic constipation mainly include irri-
tant purgative, bulk cathartic, emollient cathartic and
osmotic cathartic, as well as kinetogenic drugs and mi-
croecological preparations, etc. In treatment of chronic
functional constipation, the osmotic cathartic has more
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Table 2 Results of TGITT, M-ITT, CTT, RCTT, LCTT, RSTT at T1, T2,and T3 in the four groups ( xˉ ±s)
Notes: TGITT: total gastrointestinal transit time; M-ITT: mouth-intestine transit time; CTT: colonic transit time; RCTT: right colonic
transit time; LCTT: left colonic transit time; RSTT: rectosigmoid colonic transit time; FLM: Fuzhengliqi mixture. Compared with the
same group at T1, aP<0.01;compared with the control group at T2, bP<0.05, hP>0.05; compared with the acupuncture and FLM group at
T2, cP<0.05; compared with the same group at T2, dP>0.05, jP<0.05; compared with the control group at T3, eP<0.01, iP<0.05, kP>0.05;
compared with the acupuncture group at T3, fP<0.05; Compared with the FLM group at T3, gP<0.01.
Group
Combined
Acupuncture
FLM
Control
T
T1
T2
T3
T1
T2
T3
T1
T2
T3
T1
T2
T3
n
138
138
138
138
138
138
137
137
137
140
140
140
TGITT
82.6±14.3
21.8±4.6abc
23.3±11.4defg
82.5±12.7
33.8±6.3ah
38.3±11.3di
82.7±22.4
33.9±15.8ah
58.0±21.5jk
82.5±13.1
34.0±11.6a
58.9±1.4j
M-ITT
21.7±0.4
8.3±1.2abc
8.7±6.7defg
21.5±4.6
12.1±1.5ah
14.0±2.6di
21.6±8.9
12.2±2.5ah
21.1±0.6jk
21.6±11.3
12.2±2.8a
22.2±0.3j
CTT
60.9±21.8
13.5±1.7abc
14.6±2.9defg
61.0±7.4
21.7±5.3 ah
24.3±7.9di
61.1±17.9
21.7±14.6ah
36.9±16.9jk
60.9±20.7
21.8±0.5a
36.7±0.5j
RCTT
21.7±2.5
6.3±2.2abc
6.9±0.8defg
21.8±5.1
9.3±1.2ah
10.2±1.3di
21.7±13.5
9.4±1.8ah
15.4±7.8jk
21.9±1.4
9.5±1.4a
15.6±1.3j
LCTT
13.0±1.4
3.0±1.3abc
3.2±1.1defg
13.0±3.8
5.6±2.0ah
6.5±1.9di
12.9±8.2
5.8±2.4ah
9.9±1.8 jk
12.8±1.6
5.7±2.8a
9.7±1.2j
RSTT
26.2±9.3
4.2±3.4abc
4.5±0.6defg
26.4±1.9
6.8±0.8ah
7.6±1.2di
26.5±6.3
6.5±2.8ah
11.6±5.8jk
26.2±1.9
6.6±1.7a
11.4±1.2j
Notes: FLM: Fuzhengliqi mixture. Compared with the same group at T1, aP<0.01; compared with the control group at T2, bP<0.05, hP>
0.05; compared with the acupuncture and FLM group at T2, cP<0.05; compared with the same group at T2, dP>0.05, jP<0.05; compared
with the control group at T3, eP<0.01, iP<0.05, kP>0.05; compared with the acupuncture group at T3, fP<0.05; Compared with the FLM
group at T3, gP<0.01.
Group
Combined
Acupuncture
FLM
Control
T
T1
T2
T3
T1
T2
T3
T1
T2
T3
T1
T2
T3
n
138
138
138
138
138
138
137
137
137
140
140
140
Defecation
interval
3.96±0.52
1.31±0.46abc
1.35±0.97 defg
3.96±1.23
2.04±0.65ah
2.05±0.87di
3.98±0.34
2.05±0.98 ah
2.97±0.73jk
3.97±0.74
2.04±0.52a
2.98±0.49j
Stool
property
4.80±0.53
1.76±0.24abc
1.78±0.27defg
4.81±0.15
2.84±0.19ah
2.87±1.23di
4.80±1.32
2.85±0.46ah
3.62±1.91jk
4.79±0.35
2.84±0.37a
3.61±0.82j
Constipation
symptom
6.85±0.65
2.94±0.54abc
3.04±0.72defg
6.85±0.69
4.86±0.21ah
4.87±0.28di
6.84±0.76
4.85±0.29ah
6.04±0.43jk
6.86±0.57
4.87±0.25a
6.07±0.41j
Accompanying
symptom
7.16±1.54
4.07±1.92abc
4.12±0.52defg
7.17±4.71
5.11±1.53 ah
5.13±2.07 di
7.18±2.16
5.09±1.26ah
6.12±3.08jk
7.16±2.41
5.12±1.92a
6.14±2.45j
Total symptom
22.77±8.31
10.08±2.39abc
10.29±1.25defg
22.79±5.26
14.85±2.42ah
14.92±3.67di
22.80±7.14
14.84±2.93ah
18.75±6.28jk
22.78±8.59
14.87±3.63a
18.80±7.17j
Table 1 Results of defecation interval, stool property, constipation symptom grade, and accompanying symptom grade at T1, T2,
and T3 in the four groups ( xˉ ±s)
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obvious advantages compared with other cathartics, at-
tracting a great attention. Macrogol 4000 is a new type
of osmotic cathartics applied to clinic treatment in re-
cent years at home, which is a polymer with linear
long-chain and it can fix water molecules through hy-
drogen, making water retain in the intestine, increasing
the moisture of stool and softening stool, restoring the
volume and weight of the stool to normal, promoting
defecation, and improving constipation symptoms.
Macrogol 4000 is superior to another osmotic cathartic
lactulose in changing stool property, shortening colon-
ic transit time, so it is a recommended drug for treat-
ment of chronic functional constipation.10 Mosapride
is a derivative of benzamide and a kinetogenic drug of
new type for whole gastrointestinal tract, and also it is
a strong selective 5-HT4 receptor activator. It can ex-
cite 5-HT4 receptors on cholinergic intermediary neu-
rons and motor neurons of intermuscular plexus, in-
creasing acetylcholine release of nerve endings and the
stimulating activity of myenteric nerves on cholinergic
nerves, so as to promote gastrointestinal motor, and at
the same time, it increases positive kinetogenic effect of
anal sphincter and promotes spontaneous relaxation of
anal canal. Therefore, it can markedly shorten colonic
transit time and increase defecation times of the pa-
tients with constipation.11 Therefore, combination of
osmotic cathartic Macrogol 4000 with Mosapride
markedly alleviates clinical symptoms of constipation,
because the former functions rapid hydration and soft-
ens stool, and the latter accelerates gastrointestinal peri-
stalsis and evacuation. In the study, it was showed that
after combined treatment of Macrogol 4000 and Mo-
sapride, the defecation times, stool property, defecation
difficult symptom score, accompanying symptom
score, and gastrointestinal transit time all were signifi-
cantly improved, indicating that they could decrease
defecate interval, increase defecation times, change
stool property in the patients with FC, thus the consti-
pation symptoms relieved. However, 60 weeks after
treatment it was found that the defecate interval, stool
property, defecation difficult symptom score and ac-
companying symptom score, GITT and life quality
had obvious recurrence, suggesting the recurrence after
ceasing the drugs leading to a bad long-term efficacy.
Because of the complex prescription containing Chi-
nese rhubarb, dried citrus peel, Citrus aurantium and
Banksia rose, FLM is used to regulate Qi, activate
blood circulation and dredge intestines and has be-
come the preferred traditional Chinese medicine in
dredging stool. The results of this study showed that
FLM had a notable short-term efficacy but a poor
long-term efficacy, similar to routine Western Medi-
cine, because of recurrence after ceasing the drugs in
the treatment of FC. At present, Western Medicine
therapy often adopts long-term maintenance treat-
ment, but the cost is higher and adverse effects easily
occur, thus it is difficult for the patient to accept. Here,
the authors use Chinese Traditional Medicine and acu-
puncture therapy for reducing recurrence and lighten-
ing economic burden of the patients.
Table 3 Results of MTL and residual rate of radiopaque markers at T1, T2, and T3 in the four groups ( xˉ ±s)
Group
Combined
Acupuncture
FLM
Control
T
T1
T2
T3
T1
T2
T3
T1
T2
T3
T1
T2
T3
n
138
138
138
138
138
138
137
137
137
140
140
140
MTL (mg/L)
328.9±52.9
506.7±92.7abc
499.8±41.8defg
328.9±32.7
420.3±56.8ah
415.5±52.5di
329.0±52.5
422.5±25.5ah
370.2±71.3jk
320.0±22.2
422.5±61.5a
369.4±31.6j
Residual rate of radiopaque markers (%)
75.4±18.1
27.7±4.5abc
29.0±12.7defg
75.5±17.9
39.5±5.23ah
41.2±12.3di
75.5±24.9
40.5±10.2ah
54.9±17.6jk
75.5±14.3
40.5±41.7a
54.9±18.2j
Notes: MTL: motilin; FLM: Fuzhengliqi mixture. Compared with the same group at T1, aP<0.01; compared with the control group at T2,
bP<0.05, hP>0.05; compared with the acupuncture and FLM group at T2, cP<0.05; compared with the same group at T2, dP>0.05, jP<0.05;
compared with the control group at T3, eP<0.01, iP<0.05, kP>0.05; compared with the acupuncture group at T3, fP<0.05; Compared with
the FLM group at T3, gP<0.01.
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In Chinese Medicine, FC could be classified into the
categories of "defecation difficulty", "splenic constipa-
tion", "Yang constipation", and "Yin constipation",
that were all considered to be caused by long-term ly-
ing in bed, disturbance of functional activities of Qi,
failure of descending the stomach-Qi , dysfunction of
large intestinal transit function, or Yangming dry-heat,
or retention of pathogenic heat in the lung, impair-
ment of body fluid, as well as insufficient large intesti-
nal liquid.
Acupuncture for its treatment stresses starting out from
the whole, treating both the principal and the second-
Table 4 Scores of 8 dimensions of quality of life at T1, T2, and T3 in the four groups (score, xˉ ±s)
Group
Combined
Acupuncture
FLM
Control
T
T1
T2
T3
T1
T2
T3
T1
T2
T3
T1
T2
T3
n
138
138
138
138
138
138
137
137
137
140
140
140
PF
81.4±22.2
94.9±15.8abc
93.8±23.5defg
81.5±27.2
87.5±22.6ah
86.7±41.6di
81.4±26.3
87.4±17.0ah
84.3±10.5jk
81.4±25.3
87.4±12.6 a
84.2±25.1 j
RP
43.6±13.4
87.8±20.7abc
87.0±15.0defg
43.6±15.4
67.7±28.9ah
66.5±13.2 di
43.7±43.4
67.6±5.3ah
54.6±13.9jk
43.6±18.4
67.7±5.4a
54.6±11.6j
RE
55.6±7.2
85.4±14.3abc
84.7±23.0defg
54.6±24.15
72.9±16.7ah
71.7±36.4di
54.6±19.7
72.9±22.3ah
63.5±25.6jk
54.6±32.9
72.9±16.1a
63.5±15.8j
SF
53.6±24.8
79.0±13.3abc
77.8±26.0defg
53.6±17.1
68.0±28.5ah
66.7±39.9di
53.6±18.5
68.2±14.6ah
60.7±46.7jk
54.6±23.8
68.3±24.5a
60.6±13.2j
Group
Combined
Acupuncture
FLM
Control
T
T1
T2
T3
T1
T2
T3
T1
T2
T3
T1
T2
T3
n
138
138
138
138
138
138
137
137
137
140
140
140
MH
57.4±17.6
79.7±14.6abc
78.3±25.4defg
57.4±17.7
69.6±27.6ah
69.2±15.0di
57.4±22.4
71.0±28.6ah
65.3±19.2jk
57.4±24.4
69.9±16.5a
65.4±20.5j
VT
50.6±28.8
84.8±24.7abc
84.2±36.6defg
50.5±15.9
71.4±17.4ah
70.8±20.3di
50.6±38.7
71.3±17.5ah
62.7±29.2jk
50.6±26.5
71.5±39.5a
61.8±21.9j
BP
65.4±29.8
94.8±10.2abc
92.4±27.1defg
65.4±18.7
83.9±25.7ah
83.5±19.1di
65.4±15.8
84.0±12.8ah
74.2±18.5jk
65.4±24.6
84.0±21.8 a
74.0±19.7 j
GH
53.8±17.4
86.3±32.1abc
85.5±39.6defg
53.8±24.9
75.3±17.2ah
75.0±37.8di
53.8±12.1
75.3±15.9ah
66.7±24.3jk
54.8±13.6
75.3±37.6a
67.0±27.1j
Notes: PF: physical function; RP: role physical; RE: role emotional; SF: social function; MH: mental health; VT: vitality; BP: bodily pain;
GH: general health; FLM:Fuzhengliqi mixture. Compared with the same group at T1, aP<0.01;compared with the control group at T2, bP<
0.05, hP>0.05; compared with the acupuncture and FLM group at T2, cP<0.05; compared with the same group at T2, dP>0.05, jP<0.05;
compared with the control group at T3, eP<0.01, iP<0.05, kP>0.05; compared with the acupuncture group at T3, fP<0.05; compared with
the FLM group at T3, gP<0.01.
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ary aspects at the same time. The theories that for guid-
ing the selection of acupoints are "treating the princi-
pal aspect for acute disease, and treating the root-cause
for chronic disease" and "He-points treating diseases of
Fu-organs". Tianshu (ST 25), Dachangshu (BL 25),
Zusanli (ST 36), and Shangjuxu (ST 37) are firstly se-
lected for treatment of constipation.
Disorder of large intestinal transit function is pathogen-
esis of functional constipation. Combination of Front-
mu point, Tianshu (ST 25), with Back-shu,
Dachangshu (BL 25), of the Large Intestine, functions
dispelling Yangming Fu Qi to promote digestion and
remove stagnated foods; Shangjuxu (ST 37) is a Lower
He-point of the Large Intestine; Zusanli (ST 36) be-
longs to the Stomach Meridian of Foot-Yangming and
functions regulating the spleen and stomach, reinforc-
ing the middle-jiao and supplementing Qi. Therefore,
Tianshu (ST 25), Dachangshu (BL 25), Zusanli (ST
36) and Shangjuxu (ST 37) can promote free flow of
the large intestinal Fu Qi, so the transit function auto-
matically restores to normal, thus the constipation will
be cured.12
The present study showed that after treatment,
above-mentioned detecting indices were all significant-
ly improved in acupuncture and combination groups,
and 60 weeks after treatment, these indices did not
have significant recurrences, that's why the long-term
efficacy was good.
The possible mechanism of acupuncture is as follows:
1) FC is related with maldevelopment of nerve fibers
on the colonic wall. In deeply needling Tianshu (ST
25), the needle body directly contacting the intestinal
wall can promote intestinal canal peristalsis through
nervous and body fluids regulation, producing a cer-
tain transient therapeutic effect. Benign stimulation of
acupuncture promotes possibly regeneration of nerve fi-
bers, producing a long-term therapeutic effect on co-
lonic transit constipation.13 This possibly is an impor-
tant cause for unobvious recurrence after acupuncture
and moxibustion treatment. 2) Modern studies find
that in the patients with functional constipation, ab-
normality of gastrointestinal kinetics is related with ab-
normality of level of special gastrointestinal hormones.
Motilin is secreted by M cells in mucosa of duodenum
and the upper segment of jejunum, and it can act on
mitolin receptor on the smooth muscle, leading to the
smooth muscle contraction, stimulating intestinal ca-
nal motor; and after meals motilin level increases in the
healthy person but the plasma motilin level does not
significantly increase in the constipation patients, in
fact it tends to decrease in most patients. After punctur-
ing Zusanli (ST 36) and Shangjuxu (ST 37), motilin
level is significantly increased, restoring the stimulating
action on gastrointestinal canal.14 3) Intestinal motor
depends on muscles of intestinal walls, which are inner-
vated by sympathetic and parasympathetic nerves. At
normal state, they keep a balance and regulate intesti-
nal motor. If parasympathetic action is over sympathet-
ic action, the intestine will be over tension and the con-
tents in the intestine will be blocked. On the contrary,
it will be over relaxation, and the contents in the large
intestinal relaxing part are blocked. Electroacupuncture
at Tianshu (ST 25) and Zusanli (ST 36) excites the
parasympathetic nerve innervating colon and decreases
colonic peristalsis and increases rectal internal pressure,
making the low defecation reflex gradually normalized,
so as to restore the defecation sense, leading to defeca-
tion.
Table 5 Effective rates in the four groups
Group
Combined
Acupuncture
FLM
control
T
Short
Long
Short
Long
Short
Long
Short
Long
n
138
138
138
138
137
137
140
140
Marked
effective
68
67
44
44
45
37
46
38
Effective
41
39
29
28
30
23
32
23
Improved
24
26
38
38
36
26
36
27
Ineffective
05
06
27
28
26
51
26
52
Total effective rate [n(%)]
133 (96.38)ab
132 (95.65)cdef
111 (80.43)g
110 (79.71)ch
111 (81.02)g
86 (62.77)ij
114 (81.43)
88 (62.86) i
Notes: FLM: Fuzhengliqi mixture. compared with the short-term efficacy of the control group, aP<0.05, gP>0.05; compared with the
short-term efficacy of the acupuncture group and FLMgroup, bP<0.05; compared with the short-term efficacy of the same group, cP>0.05,
iP<0.05; compared with the long-term efficacy of the control group, dP<0.01, hP<0.05, jP>0.05; compared with the long-term efficacy of
the acupuncture group, eP<0.05; compared with the long-term efficacy of the FLM group, fP<0.01.
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Thereby, it is deduced that acupuncture has multiple
effects in regulating autonomic nerve and promoting
the secretion of gastrointestinal hormone and the re-
generation of nerve fibers. It is beneficial to the recov-
ery of intestinal function without evident side effect
and after-withdrawal relapse. The therapeutic effect of
combining acupuncture and FLM is better, worth
spreading in clinical practice.
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